BNP Paribas’s Boston Scientific BSX Stock Holding History

BNP Paribas’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.49M	Sell	45,929 -22,823	-33%	-$1.83M	0.11%	114
2025 Q4	$6.58M	Sell	68,752 -25,362	-27%	-$2.49M	0.19%	82
2025 Q3	$9.43M	Sell	94,114 -18,141	-16%	-$1.88M	0.28%	64
2025 Q2	$12.2M	Buy	112,255 +74,104	+194%	+$7.5M	0.4%	46
2025 Q1	$12.3M	Buy	38,151 +4,395	+13%	+$443K	0.51%	46
2024 Q4	$3.02M	Buy	33,756 +251	+0.7%	+$22.1K	0.02%	100
2024 Q3	$2.81M	Buy	33,505 +18,299	+120%	+$1.44M	0.12%	88
2024 Q2	$1.17M	Buy	15,206 +8,287	+120%	+$607K	0.06%	131
2024 Q1	$474K	Buy	+6,919	New	+$445K	0.02%	205

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas's BSX Position: Q1 2026 in Review

BNP Paribas reduced its Boston Scientific (BSX) stake by 33% in Q1 2026, selling an estimated $1.83M and leaving 45,929 shares worth $3.49M. The position accounts for 0.11% of the portfolio, ranked #114.

BNP Paribas first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.3M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

BNP Paribas held 45,929 shares of Boston Scientific worth $3.49M as of Q1 2026.
BNP Paribas sold 22,823 Boston Scientific shares in Q1 2026, an estimated $1.83M.
Boston Scientific made up 0.11% of BNP Paribas's portfolio in Q1 2026, its #114 holding.
BNP Paribas first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
BNP Paribas's Boston Scientific position peaked at $12.3M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.